Our aim was to describe patient characteristics and trends in the use of extracorporeal membrane oxygenation (ECMO) for the treatment of acute respiratory distress syndrome (ARDS) in the United States from 2006 to 2011.
Methods:
We used the Nationwide Inpatient Sample to isolate all patients aged 18 years who had a discharge International Classification of Diseases, Ninth Revision diagnosis of ARDS, with and without procedure codes for ECMO, between 2006 and 2011.
Results:
We examined a total of 47 911 414 hospital discharges, representing 235 911 271 hospitalizations using national weights. Of the 1 479 022 patients meeting the definition of ARDS (representing 7 281 206 discharges), 775 underwent ECMO. There was a 409% relative increase in the use of ECMO for ARDS in the United States between 2006 and 2011, from 0.0178% to 0.090% (P = .0041). Patients treated with ECMO had higher in-hospital mortality (58.6% vs 25.1%, P < .0001) and longer hospital stays (15.8 days vs 6.9 days, P < .0001). They were also younger (47.9 vs 66.4 years, P < .0001) and more likely to be male (62.2% vs 49.6%, P < .0001). The median time to initiate ECMO from the time of admission was 0.5 days (interquartile range [IQR] 4.9 days).
Conclusion:
There has been a dramatic increase in ECMO use for the treatment of ARDS in the United States.
FergusonNDFanECamporotaL. The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material. Intensive Care Med. 2012;38(10):1573–1582.
2.
RubenfeldGDCaldwellEPeabodyE. Incidence and outcomes of acute lung injury. N Engl J Med. 2005;353(16):1685–1693.
3.
RubenfeldGDHerridgeMS. Epidemiology and outcomes of acute lung injury. Chest. 2007;131(2):554–562.
4.
ZambonMVincentJL. Mortality rates for patients with acute lung injury/ARDS have decreased over time. Chest. 2008;133(5):1120–1127.
5.
PhuaJBadiaJRAdhikariNKJ. Has mortality from acute respiratory distress syndrome decreased over time?: a systematic review. Am J Respir Crit Care Med. 2009;179(3):220–227.
6.
VillarJBlancoJAñónJM. The ALIEN study: incidence and outcome of acute respiratory distress syndrome in the era of lung protective ventilation. Intensive Care Med. 2011;37(12):1932–1941.
7.
GuérinCReignierJRichardJ-C; PROSEVA Study Group. Prone positioning in severe acute respiratory distress syndrome. N Engl J Med. 2013;368(23):2159–2168.
8.
Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med. 2000;342(18):1301–1308.
9.
PapazianLForelJMGacouinA; ACURASYS Study Investigators. Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med. 2010;363(12):1107–1116.
PadenMLConradSARycusPTThiagarajanRR; ELSO Registry. Extracorporeal Life Support Organization Registry Report 2012. ASAIO J. 2013;59(3):202–210.
13.
VandenbrouckeJPvon ElmEAltmanDG; STROBE Initiative. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Epidemiology. 2007;18(6):805–835.
14.
ReynoldsHMcCunnMBorgUHabashiNCottinghamCBar-LaviY. Acute respiratory distress syndrome: estimated incidence and mortality rate in a 5 million-person population base. Crit Care. 1998;2(1):29–34.
15.
Australia and New Zealand Extracorporeal Membrane Oxygenation (ANZ ECMO) Influenza Investigators, DaviesAJonesDBaileyM. Extracorporeal Membrane Oxygenation for 2009 Influenza A(H1N1) Acute Respiratory Distress Syndrome. JAMA. 2009;302(17):1888–1895.
16.
ZangrilloABiondi-ZoccaiGLandoniG. Extracorporeal membrane oxygenation (ECMO) in patients with H1N1 influenza infection: a systematic review and meta-analysis including 8 studies and 266 patients receiving ECMO. Crit Care. 2013;17(1):r30.
17.
CombesA. Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome (EOLIA TRIAL) Clinical Trials Number NCT01470703 [Internet]. 2015. Web site. https://clinicaltrials.gov/show/NCT01470703. Accessed February 1, 2016.
18.
MitchellMDMikkelsenMEUmscheidCALeeIFuchsBDHalpernSD. A systematic review to inform institutional decisions about the use of extracorporeal membrane oxygenation during the H1N1 influenza pandemic. Crit Care Med. 2010;38(6):1398–1404.
19.
MunshiLTelesnickiTWalkeyAFanE. Extracorporeal life support for acute respiratory failure. A systematic review and metaanalysis. Ann Am Thorac Soc. 2014;11(5):802–810.
20.
SchmidtMHodgsonCCombesA. Extracorporeal gas exchange for acute respiratory failure in adult patients: a systematic review. Crit Care. 2015;19:99.
21.
PeekGJMugfordMTiruvoipatiR. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet. 2009;374(9698):1351–1363.
22.
Del SorboLCypelMFanE. Extracorporeal life support for adults with severe acute respiratory failure. Lancet Respir Med. 2014;2(2):154–164.
23.
RochAHraiechSMassonE. Outcome of acute respiratory distress syndrome patients treated with extracorporeal membrane oxygenation and brought to a referral center. Intensive Care Med. 2014;40(1):74–83.
24.
SchmidtMBaileyMSheldrakeJ. Predicting survival after extracorporeal membrane oxygenation for severe acute respiratory failure. The Respiratory Extracorporeal Membrane Oxygenation Survival Prediction (RESP) score. Am J Respir Crit Care Med. 2014;189(11):1374–1382.
25.
ParkPKDaltonHJBartlettRH. Point: Efficacy of extracorporeal membrane oxygenation in 2009 influenza A(H1N1): sufficient evidence?Chest. 2010;138(4):776–778.
26.
MorrisAHHirshbergEMillerRRIIIStatlerKDHiteRD. Counterpoint: Efficacy of extracorporeal membrane oxygenation in 2009 influenza A(H1N1): sufficient evidence?Chest. 2010;138(4):778–781;discussion 782-784.
27.
SidebothamD. Extracorporeal membrane oxygenation--understanding the evidence: CESAR and beyond. J Extra Corpor Technol. 2011;43(1):p23–26.
28.
FrancoisG. Strategy of UltraProtective Lung Ventilation With Extracorporeal CO2 Removal for New-Onset Moderate to seVere ARDS (SUPERNOVA) [Internet]. 2015. Web site. https://clinicaltrials.gov/ct2/show/NCT02282657. Accessed February 1, 2016.
